GlassScriptPhysician profile
Steven W Reed
NPI 1669462834
$6,253.49
in general payments reported to CMS, 2019-2025
40 companies · $962 in 2025
The $962 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $1,073 · 2021: $1,014 · 2022: $769 · 2023: $1,006 · 2024: $896 · 2025: $962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,864.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $971.99 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $822.01 | 2019-2025 | |
| Abbott Laboratories | $569.57 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Aveir, Mini Trek |
| Boston Scientific Corporation | $399.12 | 2019-2025 | Watchman Flx, Watchman Access System, Bodyguardian |
| Shockwave Medical, INC | $304.61 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $300.70 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $286.10 | 2021-2023 | Acist Rxi System |
| Astrazeneca Pharmaceuticals LP | $260.12 | 2020-2022 | |
| Pfizer INC. | $256.05 | 2019-2025 | |
| Abiomed | $247.00 | 2019-2022 | |
| Atricure, INC. | $234.94 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $185.12 | 2019-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $171.29 | 2019-2023 | Xarelto |
| Heartflow, INC. | $133.23 | 2023-2025 | Ffrct |
| Scpharmaceuticals INC. | $122.82 | 2024-2025 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.